Nanopharmaceuticals - 1st Edition - ISBN: 9780128177785


1st Edition

Volume 1: Expectations and Realities of Multifunctional Drug Delivery Systems

Editors: Ranjita Shegokar
Paperback ISBN: 9780128177785
Imprint: Elsevier
Published Date: 17th January 2020
Page Count: 252
Sales tax will be calculated at check-out Price includes VAT/GST

Institutional Subscription

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.


Nanopharmaceuticals: Expectations and Realities of Multifunctional Drug Delivery Systems, Volume One, examines the fabrication, optimization, biological aspects, regulatory and clinical success of nanoparticles. Reduced toxicity, industrial trends, and in vivo success stories of nanocarriers are featured in this volume. Written by a diverse range of international researchers from industry and academia, the chapters examine specific aspects of characterization and manufacturing for pharmaceutical applications as well as regulatory and policy aspects. The Multifunctional Drug Delivery Systems books provide a platform to discuss opportunities and challenges in development of micro-nanomedicine and other drug delivery systems, review industrial manufacturing challenges, discuss current and future market trends, facilitate the insight sharing within various expertise area, and establish collaborations between academic scientists, industrial and clinical researchers;

This book connects formulation scientists, regulatory experts, engineers, clinical experts and regulatory stake holders. The wide scope of the book ensures it is a valuable reference resource for researchers in both academia and the pharmaceutical industry who want to learn more about the status of drug delivery systems.

Key Features

  • Encompasses functional aspects of nanocarriers
  • Discusses Intellectual Property landscapes of micro-nano drug carriers
  • Contains in-depth investigation of specific aspects of drug delivery systems


Pharmaceutical Scientists in academia and industry; pharmacologists; regulatory experts; bioengineers

Table of Contents

  1. Product development or formulation scientists
    2. Scale up (engineering aspect) experts
    3. Regulatory experts
    4. Clinical experts
    5. Patent -IP angle (tbd)


No. of pages:
© Elsevier 2020
17th January 2020
Paperback ISBN:

About the Editor

Ranjita Shegokar

Dr. Ranjita Shegokar holds a PhD degree in Pharmaceutical Technology from the SNDT University, India, and has been postdoctoral researcher in the Department of Pharmaceutics, Biopharmaceutics and NutriCosmetics at Free University of Berlin, Germany. Since last 8 years she is working in the pharmaceutical industry in various technical/R&D roles. Currently, she serves as Director of Pharma Business Unit at Capnomed GmbH, Germany. She has authored many research articles, book chapters, and presented several research papers in conferences. She has filed multiple patent application in area of drug delivery and drug targeting. She received several national and international awards for her research. Her areas of interest include polymeric nanoparticles, nanocrystals, lipid nanoparticles (SLNs/NLCs), nanoemulsions and role of excipients in delivery systems.

Affiliations and Expertise

Director, Pharma Business Unit, Capnomed GmbH, Germany

Ratings and Reviews